{"id":"W2898155733","doi":"10.1093/annonc/mdy284.013","title":"Health-related quality of life (HRQoL) after progressive disease (PD) in SPARTAN: A phase III trial of apalutamide (APA) versus placebo (PBO) in men with nonmetastatic castration-resistant prostate cancer (nmCRPC)","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Internal medicine; Placebo; Quality of life (healthcare); Cancer; Randomized controlled trial; Oncology; Urology; Surgery; Gastroenterology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001202484,0.0009914194,0.00167033,0.0002818341,0.000258437,0.0006413,0.0005667747,0.0006900629,0.002635439],"category_scores_gemma":[0.0006966963,0.0003913594,0.001342827,0.00030747,0.0007297297,0.0004558666,0.0003557261,0.002058009,0.000301773],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004716669,"about_ca_system_score_gemma":0.0006743669,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005398093,"about_ca_topic_score_gemma":0.001388929,"domain_scores_codex":[0.9996885,0.000160292,0.00001896217,0.00004985785,0.00002905438,0.0000533342],"domain_scores_gemma":[0.9996222,0.00007571125,0.000104054,0.00002574668,0.00001786108,0.0001544325],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9080887,0.01501148,0.00652632,0.0007621881,0.001629247,0.00006760348,0.00009543278,0.001275978,0.007197146,0.00009699185,0.000785905,0.05846306],"study_design_scores_gemma":[0.5832886,0.3844084,0.02569187,0.00005732407,0.001574309,0.0002181148,0.00005168743,0.001414771,0.002107719,0.0002307932,0.000931851,0.00002470745],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964899,0.002088626,0.0001299106,0.0001199189,0.00006050198,0.0003538877,0.0002702161,0.00002204858,0.0004648934],"genre_scores_gemma":[0.9975941,0.000917072,0.0002585068,0.0001348419,0.00008252538,0.0003438285,0.0002983376,0.000003264206,0.0003675971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002635439,"threshold_uncertainty_score":0.008816481,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1343461333751848,"score_gpt":0.4763691454765236,"score_spread":0.3420230121013388,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}